Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
26 Apr 24
S-3ASR
Automatic shelf registration
26 Apr 24
424B5
Prospectus supplement for primary offering
26 Apr 24
ARS
2023 FY
Annual report to shareholders
25 Apr 24
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
10-Q
2024 Q1
Quarterly report
25 Apr 24
8-K
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
25 Apr 24
8-K
Regulation FD Disclosure
12 Mar 24
S-8
Registration of securities for employees
22 Feb 24
10-K
2023 FY
Annual report
22 Feb 24
8-K
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
22 Feb 24
8-K
Results of Operations and Financial Condition
11 Jan 24
8-K
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
3 Jan 24
8-K
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
6 Dec 23
10-Q
2023 Q3
Quarterly report
3 Nov 23
8-K
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
3 Nov 23
8-K
Results of Operations and Financial Condition
12 Oct 23
8-K
Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence
26 Sep 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
8-K
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 23
424B5
Prospectus supplement for primary offering
3 May 23
8-K
Morphic Therapeutic Announces Proposed Public Offering
3 May 23
424B5
Prospectus supplement for primary offering
2 May 23
8-K
Other Events
25 Apr 23
10-Q
2023 Q1
Quarterly report
25 Apr 23
8-K
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2023
25 Apr 23
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
PRE 14A
Preliminary proxy
10 Apr 23
D
$100.00 mm in equity, sold $100.00 mm, 4 investors
1 Mar 23
S-3ASR
Automatic shelf registration
23 Feb 23
S-8
Registration of securities for employees
23 Feb 23
10-K
2022 FY
Annual report
23 Feb 23
8-K
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2022
23 Feb 23
8-K
Entry into a Material Definitive Agreement
13 Feb 23
8-K
Termination of a Material Definitive Agreement
20 Jan 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
8-K
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2022
2 Nov 22
Latest ownership filings
4
Bruce Rogers
28 Mar 24
4
Simon Peter Cooper
19 Mar 24
3
Simon Peter Cooper
19 Mar 24
SC 13G/A
EcoR1 Capital, LLC
15 Feb 24
SC 13G/A
EcoR1 Capital, LLC
14 Feb 24
SC 13G/A
Point72 Asset Management, L.P.
14 Feb 24
SC 13G/A
Artal International S.C.A.
9 Feb 24
SC 13G/A
Polaris Partners VII, L.P.
9 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
8 Feb 24
SC 13G/A
BlackRock Inc.
26 Jan 24
SC 13G
STATE STREET CORP
24 Jan 24
4
Praveen P. Tipirneni
17 Jan 24
4
MARC SCHEGERIN
17 Jan 24
4
Bruce Rogers
17 Jan 24
4
Robert E Farrell Jr
17 Jan 24
4
William DeVaul
17 Jan 24
4
Martin Edwards
15 Nov 23
4
JOSEPH P SLATTERY
14 Nov 23
SC 13D
SPRINGER TIMOTHY A
18 Oct 23
SC 13G
Point72 Asset Management, L.P.
2 Oct 23
4
MARC SCHEGERIN
8 Sep 23
144
Notice of proposed sale of securities
7 Sep 23
4
Praveen P. Tipirneni
3 Aug 23
4
Praveen P. Tipirneni
6 Jul 23
4
Amir Nashat
30 Jun 23
4
TIMOTHY A SPRINGER
30 Jun 23
4
Bruce Rogers
23 Jun 23
4
Praveen P. Tipirneni
14 Jun 23
4
William DeVaul
9 Jun 23
4
Martin Edwards
5 Jun 23
4
NORBERT W BISCHOFBERGER
2 Jun 23
4
Gustav Christensen
2 Jun 23
4
SUSANNAH GRAY
2 Jun 23
4
Nisha Nanda
2 Jun 23
4
Amir Nashat
2 Jun 23
4
JOSEPH P SLATTERY
2 Jun 23
4
TIMOTHY A SPRINGER
2 Jun 23
4
Praveen P. Tipirneni
2 Jun 23
4
Robert E Farrell Jr
25 May 23